These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


212 related items for PubMed ID: 11606258

  • 1. Dietary cholate increases plasma levels of apolipoprotein B in mice by posttranscriptional mechanisms.
    Srivastava RA, Averna M, Srivastava N, Pape ME.
    Int J Biochem Cell Biol; 2001 Dec; 33(12):1215-26. PubMed ID: 11606258
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the apolipoprotein E by dietary lipids occurs by transcriptional and post-transcriptional mechanisms.
    Srivastava RA.
    Mol Cell Biochem; 1996 Feb 23; 155(2):153-62. PubMed ID: 8700160
    [Abstract] [Full Text] [Related]

  • 3. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA, Srivastava N, Averna M.
    Eur J Biochem; 2000 Jul 23; 267(13):4272-80. PubMed ID: 10866832
    [Abstract] [Full Text] [Related]

  • 4. In vivo regulation of low-density lipoprotein receptor and apolipoprotein B gene expressions by dietary fat and cholesterol in inbred strains of mice.
    Srivastava RA, Jiao S, Tang JJ, Pfleger BA, Kitchens RT, Schonfeld G.
    Biochim Biophys Acta; 1991 Oct 15; 1086(1):29-43. PubMed ID: 1683257
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs.
    Burnett JR, Wilcox LJ, Telford DE, Kleinstiver SJ, Barrett PH, Newton RS, Huff MW.
    Arterioscler Thromb Vasc Biol; 1997 Nov 15; 17(11):2589-600. PubMed ID: 9409231
    [Abstract] [Full Text] [Related]

  • 8. Studies on the expression of genes encoding apolipoproteins B100 and B48 and the low density lipoprotein receptor in nonhuman primates. Comparison of dietary fat and cholesterol.
    Sorci-Thomas M, Wilson MD, Johnson FL, Williams DL, Rudel LL.
    J Biol Chem; 1989 May 25; 264(15):9039-45. PubMed ID: 2722816
    [Abstract] [Full Text] [Related]

  • 9. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
    Fu T, Mukhopadhyay D, Davidson NO, Borensztajn J.
    J Biol Chem; 2004 Jul 02; 279(27):28662-9. PubMed ID: 15123680
    [Abstract] [Full Text] [Related]

  • 10. PPARalpha deficiency increases secretion and serum levels of apolipoprotein B-containing lipoproteins.
    Lindén D, Alsterholm M, Wennbo H, Oscarsson J.
    J Lipid Res; 2001 Nov 02; 42(11):1831-40. PubMed ID: 11714852
    [Abstract] [Full Text] [Related]

  • 11. Effects of stigmastanyl-phosphocholine (Ro 16-6532) and lovastatin on lipid and lipoprotein levels and lipoprotein metabolism in the hamster on different diets.
    Himber J, Missano B, Rudling M, Hennes U, Kempen HJ.
    J Lipid Res; 1995 Jul 02; 36(7):1567-85. PubMed ID: 7595080
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
    Venkatesan N, Devaraj SN, Devaraj H.
    Eur J Nutr; 2003 Oct 02; 42(5):262-71. PubMed ID: 14569407
    [Abstract] [Full Text] [Related]

  • 14. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1.
    Nakamuta M, Chang BH, Zsigmond E, Kobayashi K, Lei H, Ishida BY, Oka K, Li E, Chan L.
    J Biol Chem; 1996 Oct 18; 271(42):25981-8. PubMed ID: 8824235
    [Abstract] [Full Text] [Related]

  • 15. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD, Smirnova EA, Merched A, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biochim Biophys Acta; 2000 Feb 24; 1484(1):29-40. PubMed ID: 10685028
    [Abstract] [Full Text] [Related]

  • 16. Estrogen increases hepatic lipase levels in inbred strains of mice: a possible mechanism for estrogen-dependent lowering of high density lipoprotein.
    Srivastava N, Chowdhury PR, Averna M, Srivastava RA.
    Mol Cell Biochem; 2001 Apr 24; 220(1-2):87-93. PubMed ID: 11451387
    [Abstract] [Full Text] [Related]

  • 17. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice.
    Dichek HL, Johnson SM, Akeefe H, Lo GT, Sage E, Yap CE, Mahley RW.
    J Lipid Res; 2001 Feb 24; 42(2):201-10. PubMed ID: 11181749
    [Abstract] [Full Text] [Related]

  • 18. Increased apoB100 mRNA in inbred strains of mice by estrogen is caused by decreased RNA editing protein mRNA.
    Srivastava RA.
    Biochem Biophys Res Commun; 1995 Jul 17; 212(2):381-7. PubMed ID: 7626051
    [Abstract] [Full Text] [Related]

  • 19. Liver LDL receptor mRNA expression is decreased in human ApoB/CETP double transgenic mice and is regulated by diet as well as the cytokine oncostatin M.
    Liu J, Zhang YL, Spence MJ, Vestal RE, Wallace PM, Grass DS.
    Arterioscler Thromb Vasc Biol; 1997 Nov 17; 17(11):2948-54. PubMed ID: 9409281
    [Abstract] [Full Text] [Related]

  • 20. Relationships of plasma and hepatic variables with rates of plasma low-density lipoprotein apolipoprotein B metabolism in baboons fed low- and high-fat diets.
    Kushwaha RS, Barrett PH, Reardon CA, Lewis DS, Carey KD, Getz GS, McGill HC.
    Metabolism; 1995 Aug 17; 44(8):1058-66. PubMed ID: 7637648
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.